[PAR] QoQ Quarter Result on 30-Jun-2018 [#Q4]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
29-Jun-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q4]
Profit Trend
QoQ- 26.76%
YoY- -79.62%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 31/12/16 CAGR
Revenue 826 2,956 28 2,660 22 1,766 58 142.39%
PBT -5,104 -11,227 -4,400 -2,617 -3,573 -1,457 -2,818 21.89%
Tax 826 2,956 0 0 0 0 0 -
NP -5,104 -11,227 -4,400 -2,617 -3,573 -1,457 -2,818 21.89%
Tax Rate - - - - - - - -
Total Cost 5,930 14,183 4,428 5,277 3,596 3,223 2,876 27.27%
Ratio Analysis
31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 31/12/16 CAGR
NP Margin -617.95 -379.84 -15,637.06 -98.38 -15,998.41 -82.52 -4,891.80 -49.82%
Per Share
31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 31/12/16 CAGR
EPS -0.03 -0.08 -0.03 -0.02 -0.03 -0.01 -0.03 0.00%
EPS Diluted -0.03 -0.08 -0.03 -0.02 -0.03 -0.01 -0.03 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.